Usa Financial Portformulas Corp Danaher Corp Transaction History

Usa Financial Portformulas Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 27, 2023	SELL	$233.08 - $265.59 $466 - $531	-2 Reduced 50.0%	2 $0
Q1 2022 Aug 16, 2022	SELL	$257.27 - $315.76 $981,742 - $1.2 Million	-3,816 Reduced 99.9%	4 $1,000
Q4 2021 Feb 10, 2022	BUY	$292.08 - $329.01 $1.07 Million - $1.2 Million	3,661 Added 2302.52%	3,820 $1.26 Million
Q3 2021 Nov 08, 2021	BUY	$272.21 - $332.43 $42,736 - $52,191	157 Added 7850.0%	159 $48,000
Q2 2021 Jul 29, 2021	SELL	$225.08 - $271.69 $75,626 - $91,287	-336 Reduced 99.41%	2 $1,000
Q1 2021 May 06, 2021	SELL	$212.38 - $245.9 $1.2 Million - $1.38 Million	-5,627 Reduced 94.33%	338 $76,000
Q4 2020 Jan 29, 2021	SELL	$212.5 - $245.46 $351,687 - $406,236	-1,655 Reduced 21.72%	5,965 $1.33 Million
Q3 2020 Oct 09, 2020	BUY	$177.16 - $215.33 $1.35 Million - $1.64 Million	7,618 Added 380900.0%	7,620 $1.64 Million
Q4 2019 Feb 07, 2020	SELL	$133.47 - $153.48 $2.7 Million - $3.1 Million	-20,226 Reduced 99.99%	2 $0
Q3 2019 Nov 14, 2019	BUY	$135.4 - $146.47 $2.74 Million - $2.96 Million	20,228 New	20,228 $2.92 Million

2,509

539M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $173B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

Stay updated on Usa Financial Portformulas Corp with notifications on news.